By scrutinizing the cancer genome atlas database, we found that RNF219 expression was significantly decreased in malignant tissues of patients with cancers of breast, brain, prostate, thyroid, thymus, and uterus (Fig. S1A). The gene discussed is OBI1; the disease is cancer.